AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Phylogenetic aspects of the complement system
Authors: Zarkadis, IK Mastellos, D Lambris, JD
Citation: Ik. Zarkadis et al., Phylogenetic aspects of the complement system, DEV COMP IM, 25(8-9), 2001, pp. 745-762
Cloning and purification of the rainbow trout fifth component of complement (C5)
Authors: Franchini, S Zarkadis, IK Sfyroera, G Sahu, A Moore, WT Mastellos, D LaPatra, SE Lambris, JD
Citation: S. Franchini et al., Cloning and purification of the rainbow trout fifth component of complement (C5), DEV COMP IM, 25(5-6), 2001, pp. 419-430
Cloning and structure of three rainbow trout C3 molecules: a plausible explanation for their functional diversity
Authors: Zarkadis, IK Sarrias, MR Sfyroera, G Sunyer, JO Lambris, JD
Citation: Ik. Zarkadis et al., Cloning and structure of three rainbow trout C3 molecules: a plausible explanation for their functional diversity, DEV COMP IM, 25(1), 2001, pp. 11-24
Structure and biology of complement protein C3, a connecting link between innate and acquired immunity
Authors: Sahu, A Lambris, JD
Citation: A. Sahu et Jd. Lambris, Structure and biology of complement protein C3, a connecting link between innate and acquired immunity, IMMUNOL REV, 180, 2001, pp. 35-48
Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220
Authors: Sarrias, MR Franchini, S Canziani, G Argyropoulos, E Moore, WT Sahu, A Lambris, JD
Citation: Mr. Sarrias et al., Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220, J IMMUNOL, 167(3), 2001, pp. 1490-1499
Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: Identification of a highly inhibitory monoclonalantibody that directly recognizes the CR2-C3d interface
Authors: Guthridge, JM Young, K Gipson, MG Sarrias, MR Szakonyi, G Chen, XJS Malaspina, A Donoghue, E James, JA Lambris, JD Moir, SA Perkins, SJ Holers, VM
Citation: Jm. Guthridge et al., Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: Identification of a highly inhibitory monoclonalantibody that directly recognizes the CR2-C3d interface, J IMMUNOL, 167(10), 2001, pp. 5758-5766
A novel role of complement: Mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration
Authors: Mastellos, D Papadimitriou, JC Franchini, S Tsonis, PA Lambris, JD
Citation: D. Mastellos et al., A novel role of complement: Mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration, J IMMUNOL, 166(4), 2001, pp. 2479-2486
Structural studies in solution of the recombinant N-terminal pair of shortconsensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg
Authors: Guthridge, JM Rakstang, JK Young, KA Hinshelwood, J Aslam, M Robertson, A Gipson, MG Sarrias, MR Moore, WT Meagher, M Karp, D Lambris, JD Perkins, SJ Holers, VM
Citation: Jm. Guthridge et al., Structural studies in solution of the recombinant N-terminal pair of shortconsensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg, BIOCHEM, 40(20), 2001, pp. 5931-5941
Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons
Authors: Soulika, AM Khan, MM Hattori, T Bowen, FW Richardson, BA Hack, CE Sahu, A Edmunds, LH Lambris, JD
Citation: Am. Soulika et al., Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons, CLIN IMMUNO, 96(3), 2000, pp. 212-221
Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics
Authors: Sahu, A Lambris, JD
Citation: A. Sahu et Jd. Lambris, Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics, IMMUNOPHARM, 49(1-2), 2000, pp. 133-148
Complement and innate immunity
Authors: Song, WC Sarrias, MR Lambris, JD
Citation: Wc. Song et al., Complement and innate immunity, IMMUNOPHARM, 49(1-2), 2000, pp. 187-198
The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveA
Authors: Sarrias, MR Whitbeck, JC Rooney, I Ware, CF Eisenberg, RJ Cohen, GH Lambris, JD
Citation: Mr. Sarrias et al., The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveA, MOL IMMUNOL, 37(11), 2000, pp. 665-673
Modulation of fluid-phase complement activation inhibits hyperacute rejection in a porcine-to-human xenograft model
Authors: Fiane, AE Videm, V Lambris, JD Geiran, OR Svennevig, JL Mollnes, TE
Citation: Ae. Fiane et al., Modulation of fluid-phase complement activation inhibits hyperacute rejection in a porcine-to-human xenograft model, TRANSPLAN P, 32(5), 2000, pp. 899-900
Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1
Authors: Friedman, HM Wang, LY Pangburn, MK Lambris, JD Lubinski, J
Citation: Hm. Friedman et al., Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1, J IMMUNOL, 165(8), 2000, pp. 4528-4536
Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin
Authors: Sahu, A Soulika, AM Morikis, D Spruce, L Moore, WT Lambris, JD
Citation: A. Sahu et al., Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin, J IMMUNOL, 165(5), 2000, pp. 2491-2499
In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein (vol 190, pg 1637, 1999)
Authors: Lubinski, J Wang, LY Mastellos, D Sahu, A Lambris, JD Friedman, HM
Citation: J. Lubinski et al., In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein (vol 190, pg 1637, 1999), J EXP MED, 191(4), 2000, pp. 751-751
Complement inhibitors targeting C3, C4, and C5
Authors: Sahu, A Morikis, D Lambris, JD
Citation: A. Sahu et al., Complement inhibitors targeting C3, C4, and C5, CONT IMMUN, 9, 2000, pp. 75-112
Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts
Authors: Fiane, AE Mollnes, TE Videm, V Hovig, T Hogasen, K Mellbye, OJ Spruce, L Moore, WT Sahu, A Lambris, JD
Citation: Ae. Fiane et al., Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts, XENOTRANSPL, 6(1), 1999, pp. 52-65
Predicting peptide structures using NMR data and deterministic global optimization
Authors: Klepeis, JL Floudas, CA Morikis, D Lambris, JD
Citation: Jl. Klepeis et al., Predicting peptide structures using NMR data and deterministic global optimization, J COMPUT CH, 20(13), 1999, pp. 1354-1370
The evolution, structure, biology and pathophysiology of complement
Authors: Lambris, JD Reid, KBM Volanakis, JE
Citation: Jd. Lambris et al., The evolution, structure, biology and pathophysiology of complement, IMMUNOL TOD, 20(5), 1999, pp. 207-211
Special Issue - Papers presented at the XVIIth International Complement Workshop - Rhodes, Greece - 11-16 October 1998 - Preface
Authors: Lambris, JD Volanakis, JE
Citation: Jd. Lambris et Je. Volanakis, Special Issue - Papers presented at the XVIIth International Complement Workshop - Rhodes, Greece - 11-16 October 1998 - Preface, IMMUNOPHARM, 42(1-3), 1999, pp. IX-IX
Prolongation of ex vivo-perfused pig xenograft survival by the complement inhibitor compstatin
Authors: Fiane, AE Mollnes, TE Videm, V Hovig, T Hogasen, K Mellbye, OJ Spruce, L Moore, WT Sahu, A Lambris, JD
Citation: Ae. Fiane et al., Prolongation of ex vivo-perfused pig xenograft survival by the complement inhibitor compstatin, TRANSPLAN P, 31(1-2), 1999, pp. 934-935
Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting
Authors: Suny, XJ Funk, CD Deng, CJ Sahu, A Lambris, JD Song, WC
Citation: Xj. Suny et al., Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting, P NAS US, 96(2), 1999, pp. 628-633
Inhibition of herpes simplex virus gD and lymphotoxin-alpha binding to HveA by peptide antagonists
Authors: Sarrias, MR Whitbeck, JC Rooney, I Spruce, L Kay, BK Montgomery, RI Spear, PG Ware, CF Eisenberg, RJ Cohen, GH Lambris, JD
Citation: Mr. Sarrias et al., Inhibition of herpes simplex virus gD and lymphotoxin-alpha binding to HveA by peptide antagonists, J VIROLOGY, 73(7), 1999, pp. 5681-5687
Sea urchin coelomocytes specifically express a homologue of the complementcomponent C3 (vol 160, pg 2983, 1998)
Authors: Al-Sharif, WZ Sunyer, JO Lambris, JD Smith, LC
Citation: Wz. Al-sharif et al., Sea urchin coelomocytes specifically express a homologue of the complementcomponent C3 (vol 160, pg 2983, 1998), J IMMUNOL, 162(5), 1999, pp. 3105-3105
Risultati: 1-25 | 26-30